#OncologyMarket | Explore Tumblr posts and blogs

skyquesttinsights · 3 months ago

Text

Cell Therapy Industry: Trends and Market Insights 2024-2031

In recent years, cell therapy has emerged as a revolutionary approach in the realm of medical treatments, offering promising solutions for various chronic and life-threatening conditions. This innovative field harnesses the potential of living cells to treat diseases by repairing or replacing damaged tissues and organs. The cell therapy market is experiencing significant growth, driven by advancements in technology, increased research and development activities, and a rising prevalence of chronic diseases.

According to recent industry reports, the global cell therapy market is on a robust growth trajectory. Global Cell Therapy Market size was valued at USD 3.9 Billion in 2022 and is poised to grow from USD 6.7 Billion in 2023 to USD 190.91 Billion by 2031, growing at a CAGR of 52% during the forecast period (2024-2031). This growth is attributed to several factors, including technological advancements, a surge in clinical trials, and the increasing demand for personalized medicine.

Get Your Free Sample Report Here @ https://www.skyquestt.com/sample-request/cell-therapy-market

Key Market Drivers

1. Technological Advancements: Breakthroughs in cell processing technologies, gene editing techniques such as CRISPR, and improvements in manufacturing processes are driving the market. These advancements enhance the efficacy and safety of cell therapies, making them more accessible and effective for patients.

2. Rising Prevalence of Chronic Diseases: The growing incidence of chronic conditions such as cancer, cardiovascular diseases, and autoimmune disorders is fueling the demand for cell-based treatments. Cell therapy offers potential cures and long-term solutions for these persistent health challenges.

3. Increased Research and Development: Ongoing research efforts and clinical trials are expanding the applications of cell therapy. Investment in R&D by pharmaceutical companies and biotech firms is crucial for discovering new therapies and improving existing ones.

4. Regulatory Support: Regulatory agencies are increasingly providing clearer pathways for the approval and commercialization of cell therapies. This supportive regulatory environment is crucial for accelerating the development and market entry of new treatments.

Market Segmentation

The cell therapy market is segmented based on cell type, application, and geography.

- By Cell Type: The market includes various types of cells such as stem cells, T-cells, and dendritic cells. Stem cell therapies are particularly prominent due to their potential in regenerative medicine.

- By Application: Applications span across oncology, cardiovascular diseases, neurological disorders, and more. Oncology holds a significant share, driven by the development of CAR-T cell therapies.

- By Geography: North America dominates the market, followed by Europe and the Asia-Pacific region. The strong presence of key players and advanced healthcare infrastructure contribute to North America's leading position.

To establish the important thing traits, Ask Our Experts @ https://www.skyquestt.com/speak-with-analyst/cell-therapy-market

Cell Therapy Market Top Players' Company Profiles - Thermo Fisher Scientific, Inc., Merck KGaA, Danaher Corporation, Becton, Dickinson, and Company, Lonza Group, Sartorius AG, Nkarta, Inc., Aurion Biotech, S. BIOMEDICS, MEDIPOST, Anterogen Co., Ltd., JW Therapeutics, JCR Pharmaceuticals Co., Ltd., Johnson & Johnson Services, Inc, Bristol-Myers Squibb Company, Gilead Sciences, Inc., Novartis AG, Intellia Therapeutics, Iovance Therapeutics, CRISPR Therapeutics

Challenges and Opportunities

Despite its promising prospects, the cell therapy market faces several challenges, including high treatment costs, complex manufacturing processes, and regulatory hurdles. However, these challenges also present opportunities for innovation and improvement. Advances in manufacturing technologies, cost reduction strategies, and streamlined regulatory processes could further propel the growth of the market. The cell therapy market is poised for significant growth, driven by technological advancements, rising disease prevalence, and supportive regulatory environments. As the field continues to evolve, it holds the potential to transform the landscape of medical treatments and improve patient outcomes worldwide. Stakeholders in the healthcare industry must stay abreast of these developments to capitalize on the opportunities presented by this dynamic market.

0 notes

markresearch-blog · 7 years ago

Text

Global Oncology Market - Industry Analysis, Size, Share, Growth, Trends, and Forecast Report 2023

Albany, New York, July 21, 2017: Market Research Hub (MRH) has recently announced the addition of a fresh report, titled “Global Oncology Market to 2023 - Robust Growth Driven by Rising Prevalence and Increased Uptake of Immune Checkpoint Inhibitors” to its report offerings. The report analyze the oncology pipeline and stratify by stage of development, molecule type and molecular target, with a granular breakdown across key indications.

Request Free Sample Report: http://www.marketresearchhub.com/enquiry.php?type=S&repid=1245341

In 2012, there were 32.6 million people living with any type of cancer within five years of diagnosis. These are generally incurable once they progress to the stage where they are unresectable. Chemotherapy compounds are a mainstay treatment for cancers of all types, at various disease stages. In a typical course of therapy for cancer, multiple chemotherapy compounds are administered sequentially in combination regimens, as an adjunct to surgery and radiation therapy. Chemotherapy drugs are cytotoxic to dividing cells, meaning that they act on both healthy and malignant tissues and are fairly toxic. However, they exert more damage on malignant tissue than healthy tissue due to the rapid cell cycle of cancer cells. The key cancer indications of this report are breast, colorectal, lung, and prostate and hematological cancers.

A number of common etiologic factors have been strongly characterized as raising the risk of developing cancer, including age, chronic inflammation, gender, obesity, tobacco usage and heritable cancer syndromes. The risk of cancer increases greatly in patients over the age of 65. Populations in developed countries are projected to become increasingly aged and show rising obesity incidence, which will drive both cancer prevalence and revenue growth for its treatments.

There has been a shift towards developing targeted therapies, such as mAbs and cell therapies. Targeted therapies, by their nature, have less toxicity associated with their use and as a result can be administered to more cancer patients, who are commonly elderly and have co-morbidities, therefore increasing the overall survival of this group and the number of treatment cycles they may receive. The most commercially successful oncology treatments are mAbs such as MabThera/Rituxan, Avastin and Herceptin.

Scope

Global revenue for the oncology market is forecast to grow at a Compound Annual Growth Rate (CAGR) of 10.66%, from $118.6 billion in 2016 to $241.0 billion in 2023. Which drugs will achieve blockbuster status and how will the key player companies perform during the forecast period?

The oncology pipeline is large and fairly diverse and contains 7,773 products. How does the composition of the pipeline compare with that of the existing market? What are the most popular types of molecule type and molecular target in the pipeline?

What mechanisms of action and molecule types are most common for pipeline products being trialed in the various key indications?

How will the market shares and CAGRs of the top 20 pharma companies compare within oncology?

What proportion of the key players’ revenues will be attributable to oncology products?

Reasons to buy

Understand the current clinical and commercial landscape by considering disease pathogenesis, diagnosis, prognosis, and the treatment options available at each stage of diagnosis

Visualize the composition of the oncology market across each indication, in terms of dominant molecule types and targets, highlighting the key commercial assets and players

Analyze the oncology pipeline and stratify by stage of development, molecule type and molecular target, with a granular breakdown across key indications

Understand the growth in patient epidemiology and market revenue for the oncology market globally and across the key players and product types

Stratify the market in terms of the generic and premium product revenue split between oncology products and assess the role of these product types in the treatment of the various cancers

Identify commercial opportunities in the oncology deals landscape by analyzing trends in licensing and co-development deals

Read Full Report with TOC: http://www.marketresearchhub.com/report/global-oncology-market-to-2023-robust-growth-driven-by-rising-prevalence-and-increased-uptake-of-immune-checkpoint-inhibitors-report.html

Table of Contents:

1 Table of Contents 5 1.1 List of Tables 7 1.2 List of Figures 7 2 Introduction 10 2.1 Therapy Area Introduction 10 2.2 Symptoms 11 2.3 Diagnosis 12 2.4 Etiology and Pathophysiology 13 2.4.1 Etiology 13 2.4.2 Pathophysiology 15

3 Key Marketed Products 31 3.1 Overview 31 3.2 MabThera/Rituxan (rituximab) 32 3.3 Avastin (bevacizumab) 33 3.4 Herceptin (trastuzumab) 35

4 Pipeline Landscape Assessment 49 4.1 Overview 49 4.2 Pipeline Development Landscape 50 4.3 Molecular Targets in the Pipeline 54

Make an Enquiry: http://www.marketresearchhub.com/enquiry.php?type=enquiry&repid=1245341

About Market Research Hub:

Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

Contact Details:

90 State Street,

Albany, NY 12207,

United States

Toll Free: 866-997-4948 (US-Canada)

Tel: +1-518-621-2074

Email: [email protected]

Website: www.marketresearchhub.com/

#OncologyMarket #MedicalIndustry

0 notes